The company increased its average procedure instrument selling price from $71.60 in the fourth quarter of 2023 to $75 in the first quarter of 2024, according to a May 8 news release from Sonendo.
Total operating expenses in the first quarter were $12.3 million, a decrease from the $17 million reported in the first quarter of 2023.
In addition, Sonendo announced a strategic reset of its commercial and operational priorities, including commercial strategy, cash conservation and margin expansion, CEO Bjarne Bergheim said in the release.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place November 12–14 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
